annual EBIT:
$97.87M+$92.69M(+1787.92%)Summary
- As of today (September 16, 2025), SUPN annual earnings before interest & taxes is $97.87 million, with the most recent change of +$92.69 million (+1787.92%) on December 31, 2024.
- During the last 3 years, SUPN annual EBIT has risen by +$1.27 million (+1.32%).
- SUPN annual EBIT is now -49.13% below its all-time high of $192.40 million, reached on December 31, 2020.
Performance
SUPN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
$11.14M+$13.74M(+529.16%)Summary
- As of today (September 16, 2025), SUPN quarterly earnings before interest & taxes is $11.14 million, with the most recent change of +$13.74 million (+529.16%) on June 30, 2025.
- Over the past year, SUPN quarterly EBIT has dropped by -$7.07 million (-38.83%).
- SUPN quarterly EBIT is now -80.15% below its all-time high of $56.14 million, reached on September 30, 2020.
Performance
SUPN quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$67.94M-$7.07M(-9.43%)Summary
- As of today (September 16, 2025), SUPN TTM earnings before interest & taxes is $67.94 million, with the most recent change of -$7.07 million (-9.43%) on June 30, 2025.
- Over the past year, SUPN TTM EBIT has increased by +$27.30 million (+67.18%).
- SUPN TTM EBIT is now -62.90% below its all-time high of $183.12 million, reached on March 31, 2021.
Performance
SUPN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
SUPN EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1787.9% | -38.8% | +67.2% |
| 3 y3 years | +1.3% | -7.8% | +0.3% |
| 5 y5 years | -42.5% | -79.0% | -58.2% |
SUPN EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1787.9% | -72.0% | +166.3% | -9.4% | +1107.5% |
| 5 y | 5-year | -49.1% | +1787.9% | -80.2% | +166.3% | -62.9% | +1107.5% |
| alltime | all time | -49.1% | +215.9% | -80.2% | +157.4% | -62.9% | +207.3% |
SUPN EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $11.14M(-529.2%) | $67.94M(-9.4%) |
| Mar 2025 | - | -$2.60M(-113.3%) | $75.01M(+2.3%) |
| Dec 2024 | $97.87M(+1787.9%) | $19.56M(-50.9%) | $73.36M(+0.8%) |
| Sep 2024 | - | $39.83M(+118.7%) | $72.78M(+79.1%) |
| Jun 2024 | - | $18.21M(-528.8%) | $40.64M(+622.3%) |
| Mar 2024 | - | -$4.25M(-122.4%) | $5.63M(-58.0%) |
| Dec 2023 | $5.18M(-92.4%) | $18.99M(+147.2%) | $13.40M(-49.1%) |
| Sep 2023 | - | $7.68M(-145.7%) | $26.34M(+49.5%) |
| Jun 2023 | - | -$16.80M(-576.0%) | $17.63M(-62.1%) |
| Mar 2023 | - | $3.53M(-88.9%) | $46.51M(+2.0%) |
| Dec 2022 | $67.81M(-29.8%) | $31.93M(-3179.1%) | $45.61M(+46.2%) |
| Sep 2022 | - | -$1.04M(-108.6%) | $31.20M(-53.9%) |
| Jun 2022 | - | $12.09M(+359.3%) | $67.72M(-9.2%) |
| Mar 2022 | - | $2.63M(-85.0%) | $74.60M(-26.3%) |
| Dec 2021 | $96.60M(-49.8%) | $17.52M(-50.6%) | $101.20M(-21.2%) |
| Sep 2021 | - | $35.48M(+87.1%) | $128.48M(-13.9%) |
| Jun 2021 | - | $18.96M(-35.1%) | $149.13M(-18.6%) |
| Mar 2021 | - | $29.23M(-34.7%) | $183.12M(+0.1%) |
| Dec 2020 | $192.40M(+13.0%) | $44.80M(-20.2%) | $182.90M(+2.2%) |
| Sep 2020 | - | $56.14M(+6.0%) | $178.92M(+10.1%) |
| Jun 2020 | - | $52.95M(+82.5%) | $162.50M(+6.8%) |
| Mar 2020 | - | $29.01M(-28.9%) | $152.16M(+2.4%) |
| Dec 2019 | $170.19M(+7.5%) | $40.82M(+2.7%) | $148.57M(+0.7%) |
| Sep 2019 | - | $39.73M(-6.7%) | $147.61M(+1.6%) |
| Jun 2019 | - | $42.60M(+67.5%) | $145.36M(+5.0%) |
| Mar 2019 | - | $25.43M(-36.2%) | $138.48M(-4.1%) |
| Dec 2018 | $158.29M(+54.9%) | $39.85M(+6.4%) | $144.44M(+4.0%) |
| Sep 2018 | - | $37.48M(+4.9%) | $138.93M(+12.2%) |
| Jun 2018 | - | $35.72M(+13.8%) | $123.80M(+8.5%) |
| Mar 2018 | - | $31.39M(-8.6%) | $114.15M(+14.7%) |
| Dec 2017 | $102.19M | $34.34M(+53.7%) | $99.54M(+22.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $22.34M(-14.3%) | $81.49M(+3.2%) |
| Jun 2017 | - | $26.07M(+55.3%) | $78.99M(+22.3%) |
| Mar 2017 | - | $16.79M(+3.0%) | $64.57M(+19.1%) |
| Dec 2016 | $55.46M(+186.2%) | $16.30M(-17.9%) | $54.22M(+18.4%) |
| Sep 2016 | - | $19.84M(+70.4%) | $45.80M(+51.3%) |
| Jun 2016 | - | $11.64M(+80.9%) | $30.27M(+34.7%) |
| Mar 2016 | - | $6.44M(-18.3%) | $22.47M(+12.0%) |
| Dec 2015 | $19.38M(-514.6%) | $7.88M(+82.9%) | $20.07M(+18.6%) |
| Sep 2015 | - | $4.31M(+12.1%) | $16.92M(-59.5%) |
| Jun 2015 | - | $3.84M(-4.7%) | $41.77M(+0.2%) |
| Mar 2015 | - | $4.03M(-14.7%) | $41.69M(+72.0%) |
| Dec 2014 | -$4.67M(-94.5%) | $4.73M(-83.8%) | $24.23M(+197.5%) |
| Sep 2014 | - | $29.17M(+676.5%) | $8.14M(-121.3%) |
| Jun 2014 | - | $3.76M(-128.0%) | -$38.20M(-33.5%) |
| Mar 2014 | - | -$13.42M(+18.2%) | -$57.43M(-7.2%) |
| Dec 2013 | -$84.42M(+97.7%) | -$11.36M(-33.9%) | -$61.92M(-2.2%) |
| Sep 2013 | - | -$17.18M(+11.0%) | -$63.30M(+8.4%) |
| Jun 2013 | - | -$15.48M(-13.6%) | -$58.42M(+11.9%) |
| Mar 2013 | - | -$17.91M(+40.5%) | -$52.20M(+23.8%) |
| Dec 2012 | -$42.71M(+13.6%) | -$12.74M(+3.7%) | -$42.17M(+6.7%) |
| Sep 2012 | - | -$12.29M(+32.8%) | -$39.52M(+6.4%) |
| Jun 2012 | - | -$9.26M(+17.5%) | -$37.15M(+2.4%) |
| Mar 2012 | - | -$7.88M(-22.0%) | -$36.28M(-3.9%) |
| Dec 2011 | -$37.60M(-4.7%) | -$10.10M(+1.8%) | -$37.76M(-19.8%) |
| Sep 2011 | - | -$9.91M(+18.1%) | -$47.08M(+26.7%) |
| Jun 2011 | - | -$8.40M(-10.3%) | -$37.17M(+29.2%) |
| Mar 2011 | - | -$9.36M(-51.8%) | -$28.77M(+48.2%) |
| Dec 2010 | -$39.47M(-1053.9%) | -$19.41M(+41.5%) | -$19.41M(+41.5%) |
| Dec 2009 | $4.14M(-116.7%) | -$13.72M | -$13.72M |
| Dec 2008 | -$24.80M(+43.6%) | - | - |
| Dec 2007 | -$17.27M | - | - |
FAQ
- What is Supernus Pharmaceuticals, Inc. annual earnings before interest & taxes?
- What is the all time high annual EBIT for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. annual EBIT year-on-year change?
- What is Supernus Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
- What is Supernus Pharmaceuticals, Inc. TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Supernus Pharmaceuticals, Inc.?
- What is Supernus Pharmaceuticals, Inc. TTM EBIT year-on-year change?
What is Supernus Pharmaceuticals, Inc. annual earnings before interest & taxes?
The current annual EBIT of SUPN is $97.87M
What is the all time high annual EBIT for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high annual earnings before interest & taxes is $192.40M
What is Supernus Pharmaceuticals, Inc. annual EBIT year-on-year change?
Over the past year, SUPN annual earnings before interest & taxes has changed by +$92.69M (+1787.92%)
What is Supernus Pharmaceuticals, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of SUPN is $11.14M
What is the all time high quarterly EBIT for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high quarterly earnings before interest & taxes is $56.14M
What is Supernus Pharmaceuticals, Inc. quarterly EBIT year-on-year change?
Over the past year, SUPN quarterly earnings before interest & taxes has changed by -$7.07M (-38.83%)
What is Supernus Pharmaceuticals, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of SUPN is $67.94M
What is the all time high TTM EBIT for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high TTM earnings before interest & taxes is $183.12M
What is Supernus Pharmaceuticals, Inc. TTM EBIT year-on-year change?
Over the past year, SUPN TTM earnings before interest & taxes has changed by +$27.30M (+67.18%)